<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Kelly Musings &#187; Uncategorized</title>
	<atom:link href="http://www.kellymusings.com/category/uncategorized/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.kellymusings.com</link>
	<description>Novogen Technology</description>
	<lastBuildDate>Mon, 02 Aug 2010 23:55:17 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0</generator>
		<item>
		<title>Comment 1 August 2010</title>
		<link>http://www.kellymusings.com/comment-1-august-2010-3/</link>
		<comments>http://www.kellymusings.com/comment-1-august-2010-3/#comments</comments>
		<pubDate>Mon, 02 Aug 2010 23:55:17 +0000</pubDate>
		<dc:creator>gkelly</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.kellymusings.com/?p=475</guid>
		<description><![CDATA[First, a word to the management of Novogen and Marshall Edwards. Don’t ignore your shareholders. It is likely to be some time before the fortunes of both companies are changed around, and that means that the goodwill and support of the stock-market is going to be sorely tested in the near term. Goodwill and support [...]]]></description>
		<wfw:commentRss>http://www.kellymusings.com/comment-1-august-2010-3/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Comment 27 June</title>
		<link>http://www.kellymusings.com/comment-27-june/</link>
		<comments>http://www.kellymusings.com/comment-27-june/#comments</comments>
		<pubDate>Sun, 27 Jun 2010 07:39:00 +0000</pubDate>
		<dc:creator>gkelly</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.kellymusings.com/?p=429</guid>
		<description><![CDATA[It is not unusual for drugs to fail Phase 3 pivotal studies after showing success in Phase 2 studies. In fact, it is the norm rather than the exception. And this reality is not limited to experimental drugs … almost every major anti-cancer drug on the market today has failed at least one pivotal study [...]]]></description>
		<wfw:commentRss>http://www.kellymusings.com/comment-27-june/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
		</item>
	</channel>
</rss>
